人工器官市场机会、成长动力、产业趋势分析及 2025-2034 年预测

2024 年全球人工器官市场价值为 353 亿美元，预计 2025 年至 2034 年期间的复合年增长率为 10%。随着医疗技术的进步，人工器官越来越多地取代、支持和增强生物功能，帮助患者恢復正常。随着慢性病和器官衰竭病例的增加，对这些救生设备的需求也在激增，这加剧了对传统移植以外的替代解决方案的需求。由于捐赠器官严重短缺，人工替代品提供了一个可行的长期解决方案，大大减少了对器官捐赠的依赖。生物工程材料和尖端技术的整合正在提高设备的寿命、相容性和效率，促进医疗机构的更广泛应用。

持续的研究和开发努力正在推动人工器官设计的创新，从而改善其功能并改善患者的治疗效果。结合先进生物材料和再生医学的下一代生物人工器官正在重塑市场格局。随着 3D 生物列印技术的发展，生产客製化、针对特定患者的人工器官变得越来越可行，加速了医学的进步。随着医疗保健公司和政府机构的投资不断增加，人工器官产业将在未来十年实现大幅扩张。慢性肾臟病、肝衰竭和心血管疾病的盛行率不断上升，进一步加剧了对技术先进的器官解决方案的需求，确保了市场的持续成长。

市场按器官类型细分，包括人工肾臟、肝臟、肺臟、胰臟、心臟和其他器官。人工肾臟占最大的市场份额，2024 年市场规模达 196 亿美元。肾臟相关疾病发生率的上升推动了需求，从而推动肾臟护理技术不断进步。随着需要治疗慢性病的患者数量不断增加，创新的人工肾臟解决方案正在成为不可或缺的医疗干预措施。治疗选择的扩大和医疗能力的增强确保了市场稳步扩张。

材料细分包括硅、塑胶、钢和其他生物材料。硅在 2024 年占 36.2% 的份额，预计到 2034 年将达到 347 亿美元。其卓越的灵活性、耐用性和相容性使其成为製造先进义肢和医疗植入物的理想选择。对高性能生物材料的需求不断增加，促进了其在人造器官中的广泛应用。患者治疗效果的改善和拒绝率的降低正在加强市场定位，从而鼓励对下一代材料的进一步研究。随着技术创新不断完善人工器官设计，硅等生物相容性材料继续主导该产业。

2023 年，美国人工器官市场规模达 117 亿美元，预计到 2034 年将达到 323 亿美元。慢性病病例的增加推动了人工器官的采用，从而增加了对先进医疗解决方案的需求。器官衰竭率的上升促使医疗机构投资尖端技术。随着业界专注于开发更有效的解决方案，人造器官正在成为现代医疗保健不可或缺的一部分。製造业研究的不断扩大和改进正在加速产业成长，推动主要参与者提高生产能力。随着技术的不断进步，人工器官的采用将会增加，从而塑造医学科学和病患照护的未来。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 全球器官捐赠者短缺
    • 器官衰竭发生率上升
    • 不断进步的技术
    • 老年人口不断增加
  • 产业陷阱与挑战
    • 人造器官和手术成本高昂
    • 设备故障和併发症的风险
• 成长潜力分析
• 监管格局
• 未来市场趋势
• 差距分析
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按器官类型，2021 年至 2034 年

• 主要趋势
• 人工肾
• 人工肝
• 人工肺
• 人工胰臟
• 人工心臟
• 其他器官类型

第六章：市场估计与预测：依材料类型，2021 年至 2034 年

• 主要趋势
• 硅
• 塑胶
• 钢
• 其他材料类型

第七章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋

第八章：公司简介

• ABIOMED
• Berlin Heart
• Boston Scientific
• Cochlear
• Edwards Lifesciences
• Ekso Bionics
• Jarvik Heart
• Medtronic
• SynCardia Systems
• Zimmer Biomet

The Global Artificial Organs Market was valued at USD 35.3 billion in 2024 and is projected to register a 10% CAGR between 2025 and 2034. As medical technology advances, artificial organs are increasingly replacing, supporting, and enhancing biological functions, helping patients regain normalcy. The demand for these life-saving devices is surging as chronic illnesses and organ failure cases rise, intensifying the need for alternative solutions beyond traditional transplants. With a severe shortage of donor organs, artificial replacements offer a viable, long-term solution, significantly reducing dependency on organ donations. The integration of bioengineered materials and cutting-edge technologies is improving device longevity, compatibility, and efficiency, fostering wider adoption across healthcare facilities.

Continuous research and development efforts are propelling innovations in artificial organ design, allowing for improved functionality and better patient outcomes. Next-generation bioartificial organs, incorporating advanced biomaterials and regenerative medicine, are reshaping the market landscape. As 3D bioprinting technology gains momentum, the production of customized, patient-specific artificial organs is becoming more feasible, accelerating medical advancements. With increasing investments from healthcare companies and government bodies, the artificial organs industry is poised for substantial expansion over the next decade. The rising prevalence of chronic kidney disease, liver failure, and cardiovascular disorders is further intensifying the need for technologically advanced organ solutions, ensuring sustained market growth.

The market is segmented by organ type, including artificial kidneys, livers, lungs, pancreas, hearts, and other organs. Artificial kidneys held the largest market share, generating USD 19.6 billion in 2024. The rising incidence of kidney-related diseases is driving demand, leading to continuous advancements in renal care technologies. With a growing number of patients requiring treatment for chronic conditions, innovative artificial kidney solutions are emerging as essential medical interventions. Expanding treatment options and enhanced medical capabilities are ensuring steady market expansion.

Material segmentation includes silicon, plastic, steel, and other biomaterials. Silicon accounted for a 36.2% share in 2024 and is projected to reach USD 34.7 billion by 2034. Its superior flexibility, durability, and compatibility make it an ideal choice for manufacturing advanced prosthetics and medical implants. Increasing demand for high-performance biomaterials is contributing to its widespread usage in artificial organs. Improved patient outcomes and reduced rejection rates are strengthening market positioning, thus encouraging further research into next-generation materials. As technological innovations refine artificial organ designs, biocompatible materials like silicon continue to dominate the industry.

U.S. artificial organs market generated USD 11.7 billion in 2023 and is expected to reach USD 32.3 billion by 2034. Growing cases of chronic diseases are driving adoption, increasing the demand for advanced medical solutions. Rising organ failure rates are prompting medical institutions to invest in cutting-edge technologies. As the industry focuses on developing more efficient solutions, artificial organs are becoming an integral part of modern healthcare. Expanding research and improvements in manufacturing are accelerating industry growth, pushing key players to enhance production capabilities. With ongoing advancements, artificial organ adoption is set to increase, shaping the future of medical science and patient care.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Scarcity of organ donors globally
    • 3.2.1.2 Increasing incidence of organ failures
    • 3.2.1.3 Growing technological advancements
    • 3.2.1.4 Rising geriatric population
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of artificial organs and procedures
    • 3.2.2.2 Risk of device failure and complications
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Future market trends
• 3.6 Gap analysis
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Organ Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Artificial kidney
• 5.3 Artificial liver
• 5.4 Artificial lungs
• 5.5 Artificial pancreas
• 5.6 Artificial heart
• 5.7 Other organ types

Chapter 6 Market Estimates and Forecast, By Material Type, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Silicon
• 6.3 Plastic
• 6.4 Steel
• 6.5 Other material types

Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 India
  • 7.4.3 Japan
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 South Africa
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 ABIOMED
• 8.2 Berlin Heart
• 8.3 Boston Scientific
• 8.4 Cochlear
• 8.5 Edwards Lifesciences
• 8.6 Ekso Bionics
• 8.7 Jarvik Heart
• 8.8 Medtronic
• 8.9 SynCardia Systems
• 8.10 Zimmer Biomet